Table 2 Comparison of clinicopathological features between patients with Mt and Wt
Total n = 237 | Mt (n = 108) | Wt (n = 129) | P valuesa |
|---|---|---|---|
Age | 66.5 | 66.1 | 0.791b |
Male, (%) | 48 (44.4) | 85 (65.9) | 0.001 |
Smoking history, (%) | 52 (48.1) | 94 (72.9) | < 0.001 |
Surgical procedure, (%) | |||
pneumonectomy | 2 (1.9) | 3 (2.3) | |
lobectomy | 104 (96.2) | 124 (96.1) | |
segmentectomy | 2 (1.9) | 2 (1.6) | 0.958 |
Pathological tumor size, (mm) | 33.9 (11–100) | 40.0 (11–210) | 0.019b |
Pathological stage, (%) | |||
I | 24 (22.2) | 36 (27.9) | |
II | 26 (24.1) | 36 (27.9) | |
III | 58 (53.7) | 57 (44.2) | 0.337 |
Lymphatic invasion, (%) | 61 (56.4) | 58 (45.0) | 0.077 |
Vascular invasion, (%) | 68 (63.0) | 83 (64.3) | 0.826 |
Pleural invasion, (%) | 50 (46.3) | 72 (55.8) | 0.144 |
Nodal invasion, (%) | 81 (75.0) | 80 (62.0) | 0.033 |
Recurrence pattern | |||
locoregional | 29 (26.9) | 43 (33.3) | |
systemic | 79 (73.1) | 86 (66.7) | 0.280 |
Administration of EGFR - TKI | 81 (75.0) | 7 (5.4) | < 0.001 |